ATE313530T1 - Neuer pyridon-derivat der eine affinität für den angiotensin-ii-rezeptor hat - Google Patents

Neuer pyridon-derivat der eine affinität für den angiotensin-ii-rezeptor hat

Info

Publication number: ATE313530T1
Authority: AT; Austria
Prior art keywords: radical; angiotensin; affinity; receptor; pyridone derivative
Prior art date: 1992-02-07

Application number

AT93905369T

Other languages

English (en)

Inventor

Michel Fortin

Jean-Luc Haesslein

Bertrand Heckmann

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-02-07

Filing date

1993-02-05

Publication date

2006-01-15

1993-02-05 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2006-01-15 Application granted granted Critical

2006-01-15 Publication of ATE313530T1 publication Critical patent/ATE313530T1/de

Links

102000008873 Angiotensin II receptor Human genes 0.000 title 1
108050000824 Angiotensin II receptor Proteins 0.000 title 1
UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical class OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 title 1
125000002252 acyl group Chemical group 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
125000005018 aryl alkenyl group Chemical group 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000004104 aryloxy group Chemical group 0.000 abstract 1
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
-1 nitro, sulpho, formyl Chemical group 0.000 abstract 1
230000000144 pharmacologic effect Effects 0.000 abstract 1
125000003396 thiol group Chemical class [H]S* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)
Pyrane Compounds (AREA)

AT93905369T 1992-02-07 1993-02-05 Neuer pyridon-derivat der eine affinität für den angiotensin-ii-rezeptor hat ATE313530T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9201390A FR2687674B1 (fr)	1992-02-07	1992-02-07	Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
PCT/FR1993/000118 WO1993016049A1 (fr)	1992-02-07	1993-02-05	Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant

Publications (1)

Publication Number	Publication Date
ATE313530T1 true ATE313530T1 (de)	2006-01-15

Family

ID=9426432

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93905369T ATE313530T1 (de)	1992-02-07	1993-02-05	Neuer pyridon-derivat der eine affinität für den angiotensin-ii-rezeptor hat

Country Status (13)

Country	Link
EP (1)	EP0579819B1 (de)
JP (1)	JPH06506956A (de)
KR (1)	KR100273181B1 (de)
AT (1)	ATE313530T1 (de)
AU (1)	AU667880B2 (de)
CA (1)	CA2106758A1 (de)
DE (1)	DE69333944T2 (de)
ES (1)	ES2251714T3 (de)
FR (1)	FR2687674B1 (de)
HU (1)	HUT68756A (de)
RU (1)	RU2124004C1 (de)
WO (1)	WO1993016049A1 (de)
ZA (1)	ZA93810B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5866601A (en) *	1995-02-27	1999-02-02	Gilead Sciences, Inc.	Carbocyclic compounds
US5952375A (en)	1995-02-27	1999-09-14	Gilead Sciences, Inc.	Compounds and methods for synthesis and therapy
CN1184473A (zh) *	1995-05-19	1998-06-10	比奥塔科学管理有限公司	6－羟基酰胺－二氢吡喃衍生物
US5763483A (en) *	1995-12-29	1998-06-09	Gilead Sciences, Inc.	Carbocyclic compounds
US5859284A (en) *	1996-08-23	1999-01-12	Gilead Sciences, Inc.	Preparation of carbocyclic compounds
US6518438B2 (en)	1996-08-23	2003-02-11	Gilead Sciences, Inc.	Preparation of cyclohexene carboxylate derivatives
US5994377A (en)	1996-10-21	1999-11-30	Gilead Sciences, Inc.	Piperidine compounds
TW477783B (en) *	1997-12-12	2002-03-01	Gilead Sciences Inc	Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
US6638937B2 (en)	1998-07-06	2003-10-28	Bristol-Myers Squibb Co.	Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
WO2004078727A1 (ja) *	2003-02-05	2004-09-16	Nippon Soda Co., Ltd.	新規６－フルオロアルキル－２（１ｈ）－ピリジノン、６－フルオロアルキルピリジン化合物及びその製造方法
SE0302487D0 (sv) *	2003-09-18	2003-09-18	Astrazeneca Ab	Novel compounds
EP1749828A1 (de)	2005-08-04	2007-02-07	Farmaprojects S.L.	Verfahren zur Herstellung eines Angiotensin-II-Antagonisten
CA2789471C (en) *	2010-03-04	2018-01-02	Merck Sharp & Dohme Corp.	Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4046769A (en) *	1976-10-29	1977-09-06	Warner-Lambert Company	4,10-Dihydro-4,10-dioxo-1H-1-benzopyrano[3,2-b]pyridine-2-carboxylic acids and esters
JPS56115784A (en) *	1980-02-15	1981-09-11	Tanabe Seiyaku Co Ltd	Novel pyridinecarboxamide derivative and its preparation
NZ197027A (en) *	1980-05-12	1984-03-16	Rohm & Haas	4-oxo-2-phenyl-nicotinic acids salts and esters and growth regulating compositions
GB8412208D0 (en) *	1984-05-12	1984-06-20	Pfizer Ltd	Quinolone inotropic agents
US4886744A (en) *	1985-04-25	1989-12-12	Polaroid Corporation	Fluorescent conjugates and biological diagnostic assay system
EP0276204A3 (de) *	1987-01-07	1989-06-07	Monsanto Company	Pyridingametozide
US4747871A (en) *	1987-01-07	1988-05-31	Monsanto Company	2,6-bis(trifluoromethyl)-3-hydroxycarbonyl pyridine, salts and gametocides
US4751073A (en) *	1987-06-03	1988-06-14	Olin Corporation	Selected 2,2,6,6-tetraalkyl-4-piperidinyl derivatives and their use as light stabilizers
CA1338238C (en) *	1988-01-07	1996-04-09	David John Carini	Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
DE3826846A1 (de) *	1988-08-06	1990-02-08	Goedecke Ag	Alkoxy-4(1h)-pyridon-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
US5077142A (en) *	1989-04-20	1991-12-31	Ricoh Company, Ltd.	Electroluminescent devices
DK0403159T3 (da) *	1989-06-14	2000-08-14	Smithkline Beecham Corp	Imidazolylalkensyrer
HU217958B (hu) *	1989-06-30	2000-05-28	E. I. Du Pont De Nemours And Co.	Helyettesített imidazolszármazékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
CA2036618C (en) *	1990-02-22	2002-10-29	Akira Morimoto	Fused thiophene derivatives, their production and use
CA2037630C (en) *	1990-03-07	2001-07-03	Akira Morimoto	Nitrogen-containing heterocylic compounds, their production and use
GB9005518D0 (en) *	1990-03-12	1990-05-09	Wellcome Found	Heterocyclic compounds
AU653734B2 (en) *	1990-06-19	1994-10-13	Meiji Seika Kabushiki Kaisha	Substituted 4-biphenylmethoxypyridine derivatives
ATE128128T1 (de) *	1990-06-29	1995-10-15	Upjohn Co	Antiatherosclerotische und antithrombotische 2- amino-6-phenyl-4h-pyran-4-one.
IL98319A (en) *	1990-07-05	1997-04-15	Roussel Uclaf	Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them
GB9102803D0 (en) *	1991-02-11	1991-03-27	Ici Plc	Pyridine compounds

1992
- 1992-02-07 FR FR9201390A patent/FR2687674B1/fr not_active Expired - Fee Related
1993
- 1993-02-05 ES ES93905369T patent/ES2251714T3/es not_active Expired - Lifetime
- 1993-02-05 DE DE69333944T patent/DE69333944T2/de not_active Expired - Fee Related
- 1993-02-05 HU HU9303144A patent/HUT68756A/hu unknown
- 1993-02-05 JP JP5513829A patent/JPH06506956A/ja active Pending
- 1993-02-05 WO PCT/FR1993/000118 patent/WO1993016049A1/fr not_active Ceased
- 1993-02-05 ZA ZA93810A patent/ZA93810B/xx unknown
- 1993-02-05 EP EP93905369A patent/EP0579819B1/de not_active Expired - Lifetime
- 1993-02-05 KR KR1019930703012A patent/KR100273181B1/ko not_active Expired - Fee Related
- 1993-02-05 AT AT93905369T patent/ATE313530T1/de not_active IP Right Cessation
- 1993-02-05 RU RU93058177A patent/RU2124004C1/ru active
- 1993-02-05 AU AU36341/93A patent/AU667880B2/en not_active Ceased
- 1993-02-05 CA CA002106758A patent/CA2106758A1/fr not_active Abandoned

Also Published As

Publication number	Publication date
ZA93810B (en)	1994-02-07
HUT68756A (en)	1995-07-28
WO1993016049A1 (fr)	1993-08-19
FR2687674B1 (fr)	1995-05-19
AU3634193A (en)	1993-09-03
DE69333944D1 (de)	2006-01-26
EP0579819B1 (de)	2005-12-21
DE69333944T2 (de)	2006-08-10
CA2106758A1 (fr)	1993-08-08
FR2687674A1 (fr)	1993-08-27
JPH06506956A (ja)	1994-08-04
AU667880B2 (en)	1996-04-18
KR100273181B1 (ko)	2000-12-01
EP0579819A1 (de)	1994-01-26
RU2124004C1 (ru)	1998-12-27
HU9303144D0 (en)	1994-01-28
ES2251714T3 (es)	2006-05-01

Legal Events

Date	Code	Title	Description
2006-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69333944D1 (de)	2006-01-26	Neuer pyridon-derivat der eine affinität für den angiotensin-ii-rezeptor hat
ES2077138T3 (es)	1995-11-16	Derivados de aminocumarano, su produccion y su uso.
ES2173090T3 (es)	2002-10-16	Derivados biciclicos de la piridina, su procedimiento de preparacion, los productos intermedios obtenidos, su aplicacion como medicamentos y sus composiciones farmaceuticas que los contienen.
IT1101865B (it)	1985-10-07	Procedimento per la produzione di composti poliossidrilici a basso peso molecolare
HUT62602A (en)	1993-05-28	Process for producing pharmaceutically active hydrazine derivatives
FI875202L (fi)	1987-11-25	Steroider med en spiranring i 17-staellning, foerfarande foer framstaellning av dessa och anvaendning av dessa.
ES2177952T3 (es)	2002-12-16	Compuestos codrticoides de esteres de nitrato y su utilizacion farmaceutica.
FI833339A0 (fi)	1983-09-19	Foerfarande foer framstaellning av farmakologiskt verksamma diazabicyklo-(3,3,1)-nonaner
ES2101513T3 (es)	1997-07-01	Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ES433902A1 (es)	1976-11-16	Procedimiento para la preparacion de bencilaminas.
FR2336935A1 (fr)	1977-07-29	Nouvelles pyrimidones, leur procede de preparation et leur application
ES2054062T3 (es)	1994-08-01	N-cicloalquilalquilo benzilaminas alfa, alfa y substituidos, su procedimiento de preparacion, su utilizacion como medicamento y sus intermedios de sintesis.
IT7848637A0 (it)	1978-03-29	Procedimento per la produzione dicomposti poliossidrilici a basso peso molecolare
MY103905A (en)	1993-10-30	Aminoalkoxyphenyl derivatives, process of preparation and compositions containing the same.
MX9301045A (es)	1993-09-01	Procedimiento para preparar antagonistas receptores de fibrinogeno.
ES432613A1 (es)	1976-12-01	Procedimiento para preparar esteres de acidos pirimidintio-notiolfosforicos.
SE7411312L (de)	1975-03-10
ES8100278A1 (es)	1980-11-01	Un procedimiento para la preparacion de derivados de 5-triazina
SE8303913D0 (sv)	1983-07-08	Heterocykliska foreningar
ES470738A1 (es)	1979-01-16	Procedimiento para la obtencion de nuevos derivados de ni- trosourea
ES8101567A1 (es)	1980-12-16	Procedimiento de preparacion de nuevas trifluoroetilaminas n-sustituidas
FR2559765B1 (fr)	1986-06-13	Nouveaux derives de la phenyl-3 propene-2 amine, leur preparation et les medicaments qui les contiennent
FI904663A0 (fi)	1990-09-21	Nya substituerade alkylpiperidiner och deras anvaendning som inhibitorer i kolesterolsyntes.
MY130090A (en)	2007-05-31	Disubstituted ureas and thioureas
FR2370081A1 (fr)	1978-06-02	Matieres a mouler ignifuges a base de polyamides